2025-02-01 2026-01-31 false No description of principal activity Capium Accounts Production 1.1 NI685087 2025-02-01 2026-01-31 NI685087 bus:FullAccounts 2025-02-01 2026-01-31 NI685087 bus:Micro-entities 2025-02-01 2026-01-31 NI685087 bus:AuditExempt-NoAccountantsReport 2025-02-01 2026-01-31 NI685087 bus:SmallCompaniesRegimeForAccounts 2025-02-01 2026-01-31 NI685087 bus:PrivateLimitedCompanyLtd 2025-02-01 2026-01-31 NI685087 2025-02-01 2026-01-31 NI685087 2026-01-31 NI685087 bus:RegisteredOffice 2025-02-01 2026-01-31 NI685087 core:WithinOneYear 2026-01-31 NI685087 core:AfterOneYear 2026-01-31 NI685087 1 2025-02-01 2026-01-31 NI685087 bus:Director1 2025-02-01 2026-01-31 NI685087 bus:Director1 2026-01-31 NI685087 bus:Director1 2024-02-01 2025-01-31 NI685087 2024-02-01 NI685087 bus:LeadAgentIfApplicable 2025-02-01 2026-01-31 NI685087 2024-02-01 2025-01-31 NI685087 2025-01-31 NI685087 core:WithinOneYear 2025-01-31 NI685087 core:AfterOneYear 2025-01-31 NI685087 bus:EntityAccountantsOrAuditors 2024-02-01 2025-01-31 NI685087 core:FurnitureFittings 2025-02-01 2026-01-31 NI685087 core:FurnitureFittings 2026-01-31 NI685087 core:FurnitureFittings 2025-01-31 NI685087 core:ComputerEquipment 2025-02-01 2026-01-31 NI685087 core:ComputerEquipment 2026-01-31 NI685087 core:ComputerEquipment 2025-01-31 NI685087 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2026-01-31 NI685087 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2025-01-31 NI685087 core:CostValuation core:Non-currentFinancialInstruments 2026-01-31 NI685087 core:CostValuation core:Non-currentFinancialInstruments 2025-01-31 NI685087 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2026-01-31 NI685087 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2026-01-31 NI685087 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2026-01-31 NI685087 core:Non-currentFinancialInstruments 2026-01-31 NI685087 core:Non-currentFinancialInstruments 2025-01-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: NI685087
Northern Ireland

 

 

 

RAIDMED LTD



Unaudited Financial Statements
 


Period of accounts

Start date: 01 February 2025

End date: 31 January 2026
Director David Branagh
Registered Number NI685087
Registered Office 146 Craigs Road
Carrickfergus
BT38 9XA
Accountants Magic Beans
Co HCA 12 Cromac Place
The Gasworks
Belfast
BT7 2JB
1
  2026   2025
    £ £   £ £
(as restated)
Fixed assets   1,993      2,272 
Current assets 27,897      24,635   
Prepayments and accrued income 6,311      30,646   
Creditors: amount falling due within one year (12,474)     (10,858)  
Net current assets   21,734      44,423 
Total assets less current liabilities   23,727      46,695 
Net assets   23,727      46,695 
 

         
Capital and reserves   23,727      46,695 
 
NOTES TO THE ACCOUNTS

General Information
RAIDMED LTD is a private company, limited by shares, registered in Northern Ireland, registration number NI685087, registration address 146 Craigs Road, Carrickfergus, BT38 9XA.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 105 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention.
The financial statements are prepared in sterling which is the functional currency of the company.
Going concern basis
The director has considered the company's current financial position and expected funding requirements and has a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Accordingly, the company continues to adopt the going concern basis of accounting in preparing the financial statements.
Government grants
Government grants received are credited to deferred income. Grants towards capital expenditure are released to the income statement over the expected useful life of the assets. Grants received towards revenue expenditure are released to the income statement as the related expenditure is incurred.
Research and development expenditure
Research and development expenditure is charged to the income statement in the period in which it is incurred.
Intangible assets
Intangible assets (including purchased goodwill and patents) are amortised at rates calculated to write off the assets on a straight line basis over their estimated useful economic lives. Impairment of intangible assets is only reviewed where circumstances indicate that the carrying value of an asset may not be fully recoverable.
Licences and patents
Licences and patents are stated at cost less amortisation. Amortisation of licences is calculated on a straight line basis over the life of the licence. Amortisation of patents is calculated on a straight line basis over their estimated expected useful economic lives.
2.

Average number of employees

Average number of employees during the year was 1 (2025 : 1).


For the year ended 31 January 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:
The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.

The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.

These accounts have been prepared in accordance with the micro-entity provisions and FRS 105, the Financial Reporting Standard applicable to the micro-entities regime. The accounts have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The income statement has not been delivered to the Registrar of Companies.
The financial statements were approved by the director on 10 September 2026 and were signed by:


--------------------------------
David Branagh
Director
2